PubRank

Acta pharmaceutica Suecica (Acta Pharm Suec)

Journal PubWeight™ 136.22‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Determination of sulphapyridine and its metabolites in biological materials after administration of salicylazosulphapyridine. 1973 2.72
2 Microbiological contamination of medical preparations. 1966 2.50
3 Plasma concentrations after oral administration of different pharmaceutical preparations of clomethiazole. 1973 1.92
4 Determination of salicylazosulphapyridine in biological materials. 1973 1.79
5 Determination of free and acetylated 5-aminosalicylic acid in serum and urine after administration of salicylazosulphapyridine. 1973 1.74
6 Thapsigargine and thapsigargicine, two new histamine liberators from Thapsia garganica L. 1978 1.57
7 Studies on in-use microbial contamination of eye drops. 1978 1.35
8 Thin-layer chromatographic and thin-layer electrophoretic analysis of ergot alkaloids. Relations between structure, RM value and electrophoretic mobility in the clavine series. 1965 1.15
9 Studies on direct compression of tablets. IV. The effect of particle size on the mechanical strength of tablets. 1982 1.10
10 Binding of two adrenergic beta-receptor antagonists, alprenolol and H 93-26, to human serum proteins. 1974 1.07
11 Synthesis of some beta-adrenergic blocking agents. 1966 1.04
12 Analysis of penicillins in biological material by reversed phase liquid chromatography and post-column derivatization. 1979 0.98
13 Drug latentiation of terbutaline. In vitro serum esterase catalyzed hydrolysis of a series of acyl-substituted mono- and diesters of terbutaline. 1974 0.98
14 Studies on direct compression of tablets. XIX. The effect of particle size and shape on the mechanical strength of sodium bicarbonate tablets. 1988 0.98
15 Absorption of alprenolol in man from tablets with different rates of release. 1971 0.96
16 Rheological characterisation of self-emulsifying oil/surfactant systems. 1976 0.95
17 Studies on pyridine alkaloids and their analogues. 1967 0.95
18 The use of non-correlated log P and (log P) 2 values in quantitative structure activity relationships. 1980 0.94
19 An in vitro model for determination of drug permeability through the cornea. 1985 0.94
20 Determination of amines and quaternary ammonium ions as complexes with picrate. 3. Relations between extraction constants and the nature of the cation and of the organic phase. 1967 0.92
21 Antibacterial borazaro derivatives. II. Effect of substituents on the antibacterial activity of 5-arylsulphonyl-4-hydroxy-4,5-borazarothieno(2,3-c)pyridines and 6-arylsulphonyl-7-hydroxy-7,6-borazarothieno(3,2-c)pyridines. 1971 0.91
22 THE METABOLIC FATE OF ACETYLGLYCINEAMIDE. 1965 0.91
23 Sterilization by means of ethylene oxide. 1975 0.91
24 Antibacterial borazaro derivatives. I. 5-Arylsulphonyl-4-hydroxy-4,5-borazarothieno(2,3-c)pyridines and 6-arylsulphonyl-7-hydroxy-7,6-borazarothieno(3,2-c)pyridines. 1971 0.90
25 PHOTOMETRIC DETERMINATION OF AMINES AND QUATERNARY AMMONIUM COMPOUNDS WITH BROMOTHYMOL BLUE. 4. EXTRACTION CONSTANTS AND CALCULATION OF EXTRACTION CONDITIONS. 1965 0.90
26 Lithium absorption from sustained-release tablets (Duretter). 1968 0.90
27 Complex formation between macromolecules and drugs. 8. Binding of saccharine, N-methyl saccharine, and the diuretic drugs hydroflumethiazide and bendroflumethiazide to human serum albumin. 1973 0.90
28 Studies on tableting properties of lactose. VI. Consolidation and compaction of spray dried amorphous lactose. 1986 0.90
29 Cardiac stimulant 1-(hydroxyphenoxy)-3-isopropylamino-2-propanols. 1970 0.88
30 Studies of Swedish marine organisms. II. Muscle-relaxant alkaloids from the marine bryozoan Flustra foliacea. 1983 0.87
31 Studies on tabletting properties of lactose, Part I. The effect of initial particle size on binding properties and dehydration characteristics of lactose. 1985 0.87
32 Alkaloids of Pachycereus pecten-aboriginum, a Mexican cactus of ethnopharmacologic interest. 1978 0.87
33 Interaction between salicylic acid and indomethacin in binding to human serum albumin. 1975 0.87
34 Radial and axial tensile strength and strength variability of paracetamol tablets. 1984 0.87
35 Biological assay of cholecystokinin in guinea-pig gall-bladder in situ. 1969 0.87
36 Measurement of axial and radial tensile strength of tablets and their relation to capping. 1978 0.86
37 The self-emulsifying action of mixed surfactants in oil. 1976 0.86
38 Determination of adrenaline and noradrenaline in plasma by an isotope derivative method and ion pair liquid chromatography. 1977 0.86
39 Proceedings: "First-pass" effect and dose dependent availability as factors contributing to interindividual differences in equilibrium concentrations of alprenolol in man. 1974 0.86
40 Epsilon aminocaproic acid and reduction in fertility of male rats. 1966 0.85
41 Studies on in-use microbial contamination of multiple-dose vials. 1978 0.85
42 Determination of artesunate and dihydroartemisinine in plasma by liquid chromatography with post-column derivatization and UV-detection. 1984 0.85
43 Cyclizing compounds. I. Tertiary N-(2-bromobenzyl)-N-haloalkylamines with adrenergic blocking action. 1973 0.85
44 Plate assay methods for amino acids. 1966 0.84
45 Some physiochemical properties of the racemates and the optically active isomers of two local anaesthetic compounds. 1971 0.84
46 The formation, structure and analysis of the thermal decomposition product of baclofen. 1979 0.84
47 Mass spectra of 1-dimethylaminonaphthalene-5-sulphonyl derivatives of biogenic amines. 1968 0.84
48 Studies on direct compression of tablets. III. The effect on tablet strength of changes in particle shape and texture obtained by milling. 1982 0.83
49 Degradation of oxytocin, lysine-vasopressin, angiotensin II and angiotensin-II-amide by oxytocinase (cystine aminopeptidase). 1967 0.83
50 Autoxidation of N-hydroxyamphetamine and N-hydroxyphentermine. The formation of 2-nitroso-1-phenyl-propanes and 1-phenyl-2-propanone oxime. 1975 0.83
Next 50